HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David A Rizzieri Selected Research

Cytochromes c (Cytochrome c)

1/2021Selective ERBB2 and BCL2 Inhibition Is Synergistic for Mitochondrial-Mediated Apoptosis in MDS and AML Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David A Rizzieri Research Topics

Disease

32Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2023 - 02/2003
23Neoplasms (Cancer)
11/2023 - 02/2002
19Leukemia
01/2019 - 02/2002
13Lymphoma (Lymphomas)
01/2019 - 07/2002
10Myelodysplastic Syndromes (Myelodysplastic Syndrome)
08/2023 - 05/2008
8Graft vs Host Disease (Graft-Versus-Host Disease)
07/2023 - 02/2007
8Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2013 - 06/2004
7Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 05/2009
6Infections
01/2020 - 11/2007
6Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2015 - 02/2002
5Bronchiolitis Obliterans Syndrome
01/2023 - 07/2010
5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2013 - 02/2002
5Burkitt Lymphoma (Burkitt's Lymphoma)
02/2013 - 06/2003
4Hematologic Neoplasms (Hematological Malignancy)
11/2023 - 05/2008
4Multiple Myeloma
01/2022 - 05/2009
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
05/2009 - 02/2002
3Primary Myelofibrosis (Myelosclerosis)
07/2023 - 05/2008
3Disease Progression
01/2021 - 09/2003
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2016 - 05/2008
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2015 - 05/2013
2Hypoalbuminemia
10/2022 - 01/2019
2Hodgkin Disease (Hodgkin's Disease)
10/2015 - 09/2003
2Blast Crisis (Blast Phase)
06/2013 - 05/2008
1Acute Promyelocytic Leukemia
01/2023
1Vomiting
01/2021
1Dysgeusia (Parageusia)
01/2021
1Sepsis (Septicemia)
01/2021
1Critical Illness (Critically Ill)
01/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2021
1Chronic Disease (Chronic Diseases)
01/2021
1Diarrhea
01/2021
1Nausea
01/2021
1Delirium
12/2020
1Body Weight (Weight, Body)
01/2019
1Edema (Dropsy)
01/2019
1Thrombocytopenia (Thrombopenia)
01/2019

Drug/Important Bio-Agent (IBA)

7GemcitabineFDA Link
12/2010 - 02/2002
5Rituximab (Mabthera)FDA Link
11/2014 - 06/2003
4Alemtuzumab (Campath)FDA Link
02/2014 - 02/2002
4Monoclonal AntibodiesIBA
05/2011 - 02/2002
4Etoposide (VP 16)FDA LinkGeneric
05/2009 - 03/2003
3Cytarabine (Cytosar-U)FDA LinkGeneric
11/2023 - 12/2014
3fludarabineIBA
07/2023 - 02/2003
3tagraxofuspIBA
10/2022 - 12/2016
3venetoclaxIBA
01/2022 - 01/2019
3Azacitidine (5 Azacytidine)FDA Link
01/2022 - 12/2012
3Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2010
3Imatinib Mesylate (Gleevec)FDA Link
01/2021 - 10/2008
3Mitoxantrone (Novantrone)FDA LinkGeneric
12/2010 - 02/2002
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2004 - 03/2003
3Dihydrotachysterol (AT 10)IBA
02/2003 - 02/2002
2Retinoic Acid Receptor alphaIBA
08/2023 - 01/2023
2Busulfan (Busulfex)FDA Link
07/2023 - 03/2003
2mivebresibIBA
07/2022 - 01/2021
2CytokinesIBA
01/2020 - 10/2016
2Lenalidomide (CC 5013)FDA Link
02/2017 - 12/2012
2AnthracyclinesIBA
12/2014 - 11/2009
25'-oleoyl cytarabineIBA
12/2014 - 04/2008
2DNA (Deoxyribonucleic Acid)IBA
01/2013 - 12/2012
2CD52 AntigenIBA
05/2011 - 02/2002
2MicroRNAs (MicroRNA)IBA
12/2010 - 05/2009
2Irinotecan (Camptosar)FDA LinkGeneric
04/2008 - 07/2002
2TenascinIBA
10/2005 - 08/2004
1Histone Deacetylase InhibitorsIBA
11/2023
1tamibaroteneIBA
08/2023
1Biomarkers (Surrogate Marker)IBA
08/2023
1Melphalan (Alkeran)FDA LinkGeneric
07/2023
1Messenger RNA (mRNA)IBA
01/2023
1fostamatinibIBA
01/2023
1Aspartic Acid (Aspartate)FDA Link
10/2022
1Alanine (L-Alanine)FDA Link
10/2022
1Transaminases (Aminotransferases)IBA
10/2022
1Karyopherins (Importin)IBA
01/2022
1selinexorIBA
01/2022
1sapacitabineIBA
12/2021
1Cytochromes c (Cytochrome c)IBA
01/2021
1Local Anti-Infective Agents (Antiseptics)IBA
01/2021
1Protein Isoforms (Isoforms)IBA
01/2021
1Daunorubicin (Cerubidine)FDA LinkGeneric
01/2021
1Mitochondrial Proteins (Mitochondrial Protein)IBA
01/2021
1chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric
01/2021
1CPX-351IBA
01/2021
1Interleukin-3 Receptors (Interleukin 3 Receptor)IBA
01/2019
1HMGB1 Protein (HMG1)IBA
01/2019

Therapy/Procedure

25Therapeutics
08/2023 - 02/2002
21Cell Transplantation
11/2023 - 10/2008
13Drug Therapy (Chemotherapy)
11/2023 - 04/2002
13Transplantation
07/2017 - 04/2002
8Hematopoietic Stem Cell Transplantation
01/2023 - 08/2010
6Stem Cell Transplantation
02/2017 - 06/2004
4Induction Chemotherapy
12/2021 - 07/2009
4Homologous Transplantation
01/2017 - 02/2013
2Intravenous Infusions
01/2019 - 01/2018
2Immunotherapy
11/2014 - 10/2006
2Autologous Transplantation
11/2014 - 03/2003
2Haploidentical Transplantation
09/2010 - 11/2007
2Radiotherapy
07/2009 - 09/2003
2Organ Transplantation
06/2004 - 06/2003
1Length of Stay
01/2021
1Consolidation Chemotherapy
01/2020